PRKCI expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.518620E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.660500E-02
Normal-vs-Stage2
9.956600E-04
Normal-vs-Stage3
3.244600E-01
Normal-vs-Stage4
1.239170E-01
Stage1-vs-Stage2
1.543820E-02
Stage1-vs-Stage3
9.400600E-01
Stage1-vs-Stage4
1.712370E-01
Stage2-vs-Stage3
5.228400E-01
Stage2-vs-Stage4
2.494600E-01
Stage3-vs-Stage4
1.357400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.204620E-03
Normal-vs-AfricanAmerican
1.305600E-01
Normal-vs-Asian
1.156550E-01
Caucasian-vs-AfricanAmerican
9.885800E-01
Caucasian-vs-Asian
5.857800E-01
AfricanAmerican-vs-Asian
7.133000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.962820E-04
Normal-vs-Female
5.129700E-02
Male-vs-Female
1.563990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.948200E-01
Normal-vs-Age(41-60Yrs)
3.955500E-02
Normal-vs-Age(61-80Yrs)
5.036700E-04
Normal-vs-Age(81-100Yrs)
1.337640E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.142800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.488400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.449000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.043600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.074000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.182400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.163600E-02
Normal-vs-Daily Drinker
1.171580E-01
Normal-vs-Weekly Drinker
1.441380E-01
Normal-vs-Occasional Drinker
2.881500E-02
Normal-vs-Social Drinker
5.436100E-02
Non Drinker-vs-Daily Drinker
3.318600E-01
Non Drinker-vs-Weekly Drinker
7.086400E-01
Non Drinker-vs-Occasional Drinker
1.938470E-02
Non Drinker-vs-Social Drinker
3.643400E-01
Daily Drinker-vs-Weekly Drinker
6.730600E-01
Daily Drinker-vs-Occasional Drinker
2.659600E-01
Daily Drinker-vs-Social Drinker
9.405800E-01
Weekly Drinker-vs-Occasional Drinker
1.454990E-01
Weekly Drinker-vs-Social Drinker
7.062600E-01
Occasional Drinker-vs-Social Drinker
2.254600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.697580E-01
Normal-vs-Grade 2
4.865800E-02
Normal-vs-Grade 3
3.303000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.109560E-02
Grade 1-vs-Grade 3
2.329800E-02
Grade 1-vs-Grade 4
1.697580E-01
Grade 2-vs-Grade 3
2.647400E-01
Grade 2-vs-Grade 4
4.865800E-02
Grade 3-vs-Grade 4
3.303000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.508210E-01
Normal-vs-NonDiabetic
3.606700E-04
Diabetic-vs-NonDiabetic
1.650180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.425750E-02
Normal-vs-NoPancreatitis
6.777400E-04
Pancreatitis-vs-NoPancreatitis
9.994200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.947200E-01
Normal-vs-N1
4.987400E-04
N0-vs-N1
6.051800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.99590000041717E-07
Normal-vs-TP53-NonMutant
1.180790E-01
TP53-Mutant-vs-TP53-NonMutant
1.882120E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
